Location History:
- Guangzhou, CN (2018)
- Taizhou, CN (2019 - 2021)
Company Filing History:
Years Active: 2018-2025
Title: Innovations by Xiaoguang Wen: A Pioneer in Pharmaceutical Patents
Introduction
Xiaoguang Wen is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release medications. With a total of 5 patents to his name, Wen's work focuses on improving the efficacy and safety of drug delivery systems.
Latest Patents
One of his latest patents is the "Controlled-release tablet of ibuprofen and method for preparing same." This invention features a controlled-release tablet composed of a drug-containing immediate-release layer and a drug-containing sustained-release layer. The formulation ensures that the mass of ibuprofen in the sustained-release layer is greater than that in the immediate-release layer, providing effective analgesic effects for up to 24 hours after administration.
Another significant patent is the "Hypnotics tablet with double-layer structure." This invention describes a double-layer tablet where one layer contains holes filled with the ingredients of the other layer. The design allows for a controlled release of medication, enhancing the stability and effectiveness of the drug while ensuring patient safety.
Career Highlights
Xiaoguang Wen has worked with several companies, including Overseas Pharmaceuticals (Guangzhou) Ltd. and Overseas Pharmaceuticals Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.
Collaborations
Wen has collaborated with notable colleagues such as Xiaofeng Huang and Dachuan Zhao. Their combined efforts have led to advancements in pharmaceutical formulations and drug delivery systems.
Conclusion
Xiaoguang Wen's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to enhancing drug efficacy and patient safety. His work continues to influence the field of pharmaceuticals significantly.